| Q35566267 | Comorbidity of psychopathological domains in community-dwelling persons with Alzheimer's disease |
| Q36655153 | Divalproex sodium for the treatment of behavioural problems associated with dementia in the elderly |
| Q40223168 | Electrocardiographic monitoring for new prescriptions of quetiapine co-prescribed with acetylcholinesterase inhibitors or memantine from 2005 to 2009. A population study on community-dwelling older people in Italy. |
| Q35226430 | Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach |
| Q36310518 | Locus Coeruleus, norepinephrine and Aβ peptides in Alzheimer's disease |
| Q42133419 | Psychotic symptoms in the elderly |
| Q93040652 | Subjective Versus Objective Outcomes of Antipsychotics for the Treatment of Neuropsychiatric Symptoms Associated with Dementia |
| Q52566537 | The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome. |
| Q37712705 | The Early Presentation of Dementia in People with Down Syndrome: a Systematic Review of Longitudinal Studies. |
| Q36923575 | The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors |
| Q42702646 | Validity of the Korean Version of the Face, Legs, Activity, Cry, and Consolability Scale for Assessment of Pain in Dementia Patients. |
| Q47102223 | Vascular dementia: Cognitive, functional and behavioral assessment. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Part II. |
| Q60923324 | characterization of a novel norepinephrine transporter PET tracer [F]NS12137 in adult and immature Sprague-Dawley rats |